MedPath
FDA Approval

AZACTAM

March 17, 2023

HUMAN PRESCRIPTION DRUG LABEL

Aztreonam(1 g in 1 1)

Manufacturing Establishments (2)

Corden Pharma Latina S.p.A.

E.R. Squibb & Sons, L.L.C.

339062883

Curia Spain, S.A.U.

E.R. Squibb & Sons, L.L.C.

563371111

Products (2)

AZACTAM

0003-2560

NDA050580

NDA (C73594)

INTRAMUSCULAR, INTRAVENOUS

September 27, 2022

AztreonamActive
Code: G2B4VE5GH8Class: ACTIBQuantity: 1 g in 1 1
arginineInactive
Code: 94ZLA3W45FClass: IACTQuantity: 0.78 g in 1 1

AZACTAM

0003-2570

NDA050580

NDA (C73594)

INTRAMUSCULAR, INTRAVENOUS

September 27, 2022

arginineInactive
Code: 94ZLA3W45FClass: IACTQuantity: 1.54 g in 1 1
AztreonamActive
Code: G2B4VE5GH8Class: ACTIBQuantity: 2 g in 1 1

Drug Labeling Information

HOW SUPPLIED SECTION

HOW SUPPLIED

AZACTAM**®**** (aztreonam for injection, USP)**

Single-dose vials:

•** 1 gram/vial:**

Packages of 10

NDC 0003-2560-16

•** 2 grams/vial:**

Packages of 10

NDC 0003-2570-16

Storage

Store in original package at 20°C to 25°C (68°F to 77°F) [see USP controlled room temperature]; avoid excessive heat.


© Copyright 2025. All Rights Reserved by MedPath